Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1953 1
1954 1
1955 1
1957 1
1958 1
1959 1
1961 2
1962 3
1963 1
1964 3
1965 1
1968 2
1969 3
1970 2
1971 1
1972 3
1973 3
1974 1
1975 7
1976 8
1977 9
1978 7
1979 7
1980 5
1981 13
1982 14
1983 11
1984 10
1985 12
1986 12
1987 14
1988 13
1989 19
1990 17
1991 12
1992 17
1993 19
1994 19
1995 31
1996 26
1997 21
1998 29
1999 27
2000 18
2001 21
2002 34
2003 24
2004 32
2005 17
2006 33
2007 37
2008 47
2009 36
2010 34
2011 36
2012 37
2013 43
2014 39
2015 49
2016 47
2017 50
2018 36
2019 34
2020 44
2021 53
2022 54
2023 49
2024 43
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,244 results

Results by year

Filters applied: . Clear all
Page 1
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M; SOLSTICE Trial Investigators. Avery RK, et al. Among authors: fournier m. Clin Infect Dis. 2022 Sep 10;75(4):690-701. doi: 10.1093/cid/ciab988. Clin Infect Dis. 2022. PMID: 34864943 Free PMC article. Clinical Trial.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, André M, Fournier M, Gaulard P, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators. Peyrade F, et al. Among authors: fournier m. Lancet Oncol. 2011 May;12(5):460-8. doi: 10.1016/S1470-2045(11)70069-9. Epub 2011 Apr 7. Lancet Oncol. 2011. PMID: 21482186 Clinical Trial.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Papanicolaou GA, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Fournier M, Murray RA, Wu J, Winston DJ; AURORA Trial Investigators. Papanicolaou GA, et al. Among authors: fournier m. Clin Infect Dis. 2024 Mar 20;78(3):562-572. doi: 10.1093/cid/ciad709. Clin Infect Dis. 2024. PMID: 38036487 Free PMC article. Clinical Trial.
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
Chou S, Alain S, Cervera C, Chemaly RF, Kotton CN, Lundgren J, Papanicolaou GA, Pereira MR, Wu JJ, Murray RA, Buss NE, Fournier M. Chou S, et al. Among authors: fournier m. J Infect Dis. 2024 Feb 14;229(2):413-421. doi: 10.1093/infdis/jiad293. J Infect Dis. 2024. PMID: 37506264 Free PMC article. Clinical Trial.
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
Sokal A, Barba-Spaeth G, Hunault L, Fernández I, Broketa M, Meola A, Fourati S, Azzaoui I, Vandenberghe A, Lagouge-Roussey P, Broutin M, Roeser A, Bouvier-Alias M, Crickx E, Languille L, Fournier M, Michel M, Godeau B, Gallien S, Melica G, Nguyen Y, Canoui-Poitrine F, Pirenne F, Megret J, Pawlotsky JM, Fillatreau S, Reynaud CA, Weill JC, Rey FA, Bruhns P, Mahévas M, Chappert P. Sokal A, et al. Among authors: fournier m. Immunity. 2023 Sep 12;56(9):2137-2151.e7. doi: 10.1016/j.immuni.2023.07.007. Epub 2023 Aug 4. Immunity. 2023. PMID: 37543032 Free article.
CMOS electrochemical pH localizer-imager.
Jung HS, Jung WB, Wang J, Abbott J, Horgan A, Fournier M, Hinton H, Hwang YH, Godron X, Nicol R, Park H, Ham D. Jung HS, et al. Among authors: fournier m. Sci Adv. 2022 Jul 29;8(30):eabm6815. doi: 10.1126/sciadv.abm6815. Epub 2022 Jul 27. Sci Adv. 2022. PMID: 35895813 Free PMC article.
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.
Piffoux M, Jacquemin J, Pétéra M, Durand S, Abila A, Centeno D, Joly C, Lyan B, Martin AL, Everhard S, Boyault S, Pistilli B, Fournier M, Rouanet P, Havas J, Sauterey B, Campone M, Tarpin C, Mouret-Reynier MA, Rigal O, Petit T, Lasset C, Bertaut A, Cottu P, André F, Vaz-Luis I, Pujos-Guillot E, Drouet Y, Trédan O. Piffoux M, et al. Among authors: fournier m. Clin Cancer Res. 2024 Oct 15;30(20):4654-4666. doi: 10.1158/1078-0432.CCR-24-0195. Clin Cancer Res. 2024. PMID: 39106085
An Aqueous Analog MAC Machine.
Jung WB, Jung HS, Wang J, Hinton H, Fournier M, Horgan A, Godron X, Nicol R, Ham D. Jung WB, et al. Among authors: fournier m. Adv Mater. 2023 Sep;35(37):e2205096. doi: 10.1002/adma.202205096. Epub 2022 Sep 9. Adv Mater. 2023. PMID: 35998945
The ICOS-ICOSL pathway tunes thymic selection.
Dong M, Chang J, Lebel MÈ, Gervais N, Fournier M, Mallet Gauthier È, Suh WK, Melichar HJ. Dong M, et al. Among authors: fournier m. Immunol Cell Biol. 2022 Mar;100(3):205-217. doi: 10.1111/imcb.12520. Epub 2022 Jan 23. Immunol Cell Biol. 2022. PMID: 34962663 Free PMC article.
The small nucleolar RNAs.
Maxwell ES, Fournier MJ. Maxwell ES, et al. Among authors: fournier mj. Annu Rev Biochem. 1995;64:897-934. doi: 10.1146/annurev.bi.64.070195.004341. Annu Rev Biochem. 1995. PMID: 7574504 Review.
1,244 results